retatrutide trial phase Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized 2a Lilly's retatrutide delivers promising results

The weight loss achieved with both compounds far exceeds results from lifestyle interventions alone, which typically produce 3-5% reductions that prove difficult to maintain

Frequently Asked Questions What is Retatrutide and how is it different from Tirzepatide

Retatrutide is a novel peptide medication designed to target multiple hormone receptors involved in appetite regulation, blood sugar control, and fat metabolism

This delayed gastric emptyingtypically lasting 30 to 90 minutes longer than normalgives your brain more time to register fullness signals, reducing appetite and food intake

Natural, unprocessed foods contain all the essential micronutrients you need, plus phytonutrients, fiber, and more

The association between second-line oral antihyperglycemic medication on types of dementia in type 2 diabetes: a nationwide real-world longitudinal study